Unicam may be available in the countries listed below.
Piroxicam is reported as an ingredient of Unicam in the following countries:
International Drug Name Search
Izilox may be available in the countries listed below.
Moxifloxacin hydrochloride (a derivative of Moxifloxacin) is reported as an ingredient of Izilox in the following countries:
International Drug Name Search
Pamidronaat Mayne may be available in the countries listed below.
Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamidronaat Mayne in the following countries:
International Drug Name Search
Mannitolo Panpharma may be available in the countries listed below.
Mannitol is reported as an ingredient of Mannitolo Panpharma in the following countries:
International Drug Name Search
Sizopril may be available in the countries listed below.
Clozapine is reported as an ingredient of Sizopril in the following countries:
International Drug Name Search
Voveran Emulgel may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voveran Emulgel in the following countries:
International Drug Name Search
Fluconazol EG may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazol EG in the following countries:
International Drug Name Search
ACC eco may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of ACC eco in the following countries:
International Drug Name Search
Diarzero may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Diarzero in the following countries:
International Drug Name Search
Rec.INN
0057648-21-2
C22-H24-F-N3-O-S
397
Neuroleptic
1-Butanone, 4-[4-(2,3-dihydro-2-thioxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-(4-fluorophenyl)-
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Undestor may be available in the countries listed below.
Testosterone undecanoate (a derivative of Testosterone) is reported as an ingredient of Undestor in the following countries:
International Drug Name Search
Curadies Ibuprofen may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Curadies Ibuprofen in the following countries:
International Drug Name Search
Nifédipine may be available in the countries listed below.
Nifédipine (DCF) is known as Nifedipine in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Acamprosate Calcium may be available in the countries listed below.
Acamprosate Calcium (BANM, USAN) is known as Acamprosate in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| USAN | United States Adopted Name |
Invi-Rase may be available in the countries listed below.
Saquinavir mesilate (a derivative of Saquinavir) is reported as an ingredient of Invi-Rase in the following countries:
International Drug Name Search
Doxazosin Hexal may be available in the countries listed below.
Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosin Hexal in the following countries:
International Drug Name Search
Gemcitabin Gry may be available in the countries listed below.
Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemcitabin Gry in the following countries:
International Drug Name Search
Taro-Mometasone may be available in the countries listed below.
Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Taro-Mometasone in the following countries:
International Drug Name Search
Blesin may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Blesin in the following countries:
International Drug Name Search
Glimepirida Normon may be available in the countries listed below.
Glimepiride is reported as an ingredient of Glimepirida Normon in the following countries:
International Drug Name Search
Antidepressants may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults. However, depression and certain other mental problems may also increase the risk of suicide. Talk with the patient's doctor to be sure that the benefits of using Remeron outweigh the risks.
Families and caregivers must closely watch patients who take Remeron. It is important to keep in close contact with the patient's doctor. Tell the doctor right away if the patient has symptoms like worsened depression, suicidal thoughts, or changes in behavior. Discuss any questions with the patient's doctor.
Treating depression. It may also be used for other conditions as determined by your doctor.
Remeron is a tetracyclic antidepressant. Exactly how Remeron improves depression symptoms is not known. It is thought to increase the activity of certain chemicals in the brain (eg, norepinephrine, serotonin) that help improve mood.
Contact your doctor or health care provider right away if any of these apply to you.
Treatments for depression are getting better everyday and there are things you can start doing right away.
Some medical conditions may interact with Remeron. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Remeron. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Remeron may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Remeron as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Remeron.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Abnormal dreams; abnormal thinking; constipation; dizziness; drowsiness; dry mouth; flu symptoms; increased appetite; weakness; weight gain.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); mouth sores; new or worsening agitation, panic attacks, aggressiveness, impulsiveness, irritability, hostility, exaggerated feeling of well-being, trouble sleeping, restlessness, or inability to sit still; red, swollen, blistered, or peeling skin; seizures; severe headache or dizziness; sluggishness; suicidal thoughts or actions; symptoms of infection (eg, fever, chills, sore throat); tremors; unusual or severe mental or mood changes; worsening of depression.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Remeron side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; disorientation; drowsiness or deep sleep; fast heartbeat; impaired memory; loss of consciousness; rigid muscles; sluggishness.
Store Remeron at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Remeron out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Remeron. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Cefodimex may be available in the countries listed below.
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Cefodimex in the following countries:
International Drug Name Search
Rec.INN
P01AX08
0003810-35-3
C8-H5-N3-O3-S2
255
Antiprotozoal
2-Thiophenecarboxamide, N-(5-nitro-2-thiazolyl)-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Enalapril + Idroclorotiazide EG may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril + Idroclorotiazide EG in the following countries:
Hydrochlorothiazide is reported as an ingredient of Enalapril + Idroclorotiazide EG in the following countries:
International Drug Name Search
Gamathiazid may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Gamathiazid in the following countries:
International Drug Name Search
Neazina may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfadimidine is reported as an ingredient of Neazina in the following countries:
International Drug Name Search
Canesten Gyn Orifarm may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Canesten Gyn Orifarm in the following countries:
International Drug Name Search
Enalapril Bexal may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Bexal in the following countries:
International Drug Name Search
Céfuroxime Kabi may be available in the countries listed below.
Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Céfuroxime Kabi in the following countries:
International Drug Name Search
Kreon may be available in the countries listed below.
Pancreatin is reported as an ingredient of Kreon in the following countries:
International Drug Name Search
Inalacor may be available in the countries listed below.
Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Inalacor in the following countries:
International Drug Name Search
Hypnocalm may be available in the countries listed below.
Flunitrazepam is reported as an ingredient of Hypnocalm in the following countries:
International Drug Name Search
Paracetamol beta may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paracetamol beta in the following countries:
International Drug Name Search
Hydroclonazone may be available in the countries listed below.
Tosylchloramide Sodium is reported as an ingredient of Hydroclonazone in the following countries:
International Drug Name Search
Emetal may be available in the countries listed below.
Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Emetal in the following countries:
International Drug Name Search
Microshield may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Microshield in the following countries:
Triclosan is reported as an ingredient of Microshield in the following countries:
International Drug Name Search
Remicaine may be available in the countries listed below.
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Remicaine in the following countries:
International Drug Name Search
Delice may be available in the countries listed below.
Lindane is reported as an ingredient of Delice in the following countries:
International Drug Name Search
Xolamin may be available in the countries listed below.
Clemastine fumarate (a derivative of Clemastine) is reported as an ingredient of Xolamin in the following countries:
International Drug Name Search
Depakine Zuur may be available in the countries listed below.
Valproic Acid is reported as an ingredient of Depakine Zuur in the following countries:
International Drug Name Search
Postinin may be available in the countries listed below.
Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Postinin in the following countries:
International Drug Name Search
Hospasol may be available in the countries listed below.
Sodium Bicarbonate is reported as an ingredient of Hospasol in the following countries:
International Drug Name Search
Fluvoxamin-Teva may be available in the countries listed below.
Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Fluvoxamin-Teva in the following countries:
International Drug Name Search
Denavir is a brand name of penciclovir topical, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Denavir available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Denavir. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Terry White Chemists Paroxetine may be available in the countries listed below.
Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Terry White Chemists Paroxetine in the following countries:
International Drug Name Search
Bykahépar may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Clanobutin is reported as an ingredient of Bykahépar in the following countries:
Clanobutin sodium salt (a derivative of Clanobutin) is reported as an ingredient of Bykahépar in the following countries:
International Drug Name Search
Tramundal may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramundal in the following countries:
International Drug Name Search
Glucotika may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Glucotika in the following countries:
International Drug Name Search
Plendil Plus may be available in the countries listed below.
Felodipine is reported as an ingredient of Plendil Plus in the following countries:
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Plendil Plus in the following countries:
International Drug Name Search
Lalide may be available in the countries listed below.
Nimesulide is reported as an ingredient of Lalide in the following countries:
International Drug Name Search
Urosan may be available in the countries listed below.
Pipemidic Acid is reported as an ingredient of Urosan in the following countries:
International Drug Name Search
Neuractin may be available in the countries listed below.
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Neuractin in the following countries:
International Drug Name Search
Beneflur may be available in the countries listed below.
Fludarabine phosphate (a derivative of Fludarabine) is reported as an ingredient of Beneflur in the following countries:
International Drug Name Search
Zolpidem AbZ may be available in the countries listed below.
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem AbZ in the following countries:
International Drug Name Search
Ranitidine Ratiopharm may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidine Ratiopharm in the following countries:
International Drug Name Search
Rx only
Oralone® (Triamcinolone Acetonide Dental Paste USP, 0.1%), contains the corticosteroid triamcinolone acetonide in an adhesive vehicle suitable for application to oral tissues. Triamcinolone acetonide is designated chemically as 9-fluoro-11β, 16α, 17, 21-tetrahydroxypregna-1, 4-diene-3, 20-dione cyclic 16, 17-acetal with acetone. The structural formula of triamcinolone acetonide is as follows:
C24H31FO6 MW 434.50
Each gram of Oralone® contains 1 mg triamcinolone acetonide in an emollient dental paste containing gelatin, pectin, and carboxymethylcellulose sodium in a plasticized hydrocarbon gel (a polyethylene and mineral oil gel base).
Like other topical corticosteroids, triamcinolone acetonide has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.
The extent of absorption through the oral mucosa is determined by multiple factors including the vehicle, the integrity of the mucosal barrier, the duration of therapy, and the presence of inflammation and/or other disease processes. Once absorbed through the mucous membranes, the disposition of corticosteroids is similar to that of systemically administered corticosteroids. Corticosteroids are bound to the plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys; some corticosteroids and their metabolites are also excreted into the bile.
Oralone® (Triamcinolone Acetonide Dental Paste USP, 0.1%) is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma.
Oralone® is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat.
Oralone® may cause local adverse reactions. If irritation develops, Oralone® should be discontinued and appropriate therapy instituted. Allergic contact sensitization with corticosteroids is usually diagnosed by observing failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing.
If concomitant mucosal infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Oralone® should be discontinued until the infection has been adequately controlled. If significant regeneration or repair of oral tissues has not occurred in seven days, additional investigation into the etiology of the oral lesion is advised.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, glucosuria, and other adverse effects known to occur with parenterally-administered steroid preparations; therefore, it may be advisable to periodically evaluate patients on prolonged therapy with corticosteroid-containing dental pastes for evidence of HPA axis suppression (see PRECAUTIONS, Laboratory Tests). If HPA axis suppression is noted, an attempt should be made to withdraw the drug or to reduce the frequency of application. Recovery of HPA axis function is generally prompt and complete upon discontinuation of therapy.
Patients using topical corticosteroids should receive the following information and instructions:
A urinary free cortisol test and ACTH stimulation test may be helpful in evaluating HPA axis suppression.
Animal studies have not been performed to evaluate triamcinolone acetonide for potential to induce carcinogenesis, mutagenesis, or impairment of fertility.
Triamcinolone acetonide has been shown to induce teratogenic effects in several species. In mice and rabbits, triamcinolone acetonide induced an increased incidence of cleft palate at dosages of approximately 120 µg/kg/day and 24 µg/kg/day, respectively (approximately 12 times and 10 times the amount in a typical daily human dose of Oralone® when compared following normalization of the data on the basis of body surface area estimates, respectively). In monkeys, triamcinolone acetonide induced cranial skeletal malformations at the lowest dosage studied (500 µg/kg/day), which was approximately 200 times the amount in a typical daily human dose of Oralone® when compared following normalization of the data on the basis of body surface area estimates. There are no adequate and well-controlled studies in pregnant women. However, a retrospective analysis of birth defects among children born to mothers that used drugs of the same class as Oralone® (corticosteroids) during pregnancy found an approximately 3 times increased incidence of cleft palate. Oralone® should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known whether oral application of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Caution should be exercised when corticosteroid-containing dental pastes are prescribed for a nursing woman.
The safety and efficacy of Oralone® in children is unknown. Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's Syndrome than mature patients because of a larger skin surface area to body weight ratio. Administration of corticosteroid-containing dental pastes to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.
Clinical studies of Oralone® did not include sufficient numbers of subjects age 65 and older to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.
The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa.
Also, see PRECAUTIONS for potential effects of systemic absorption.
Press a small dab (about 1/4 inch) to the lesion until a thin film develops. A larger quantity may be required for coverage of some lesions. For optimal results use only enough to coat the lesion with a thin film. Do not rub in. Attempting to spread this preparation may result in granular, gritty sensation and cause it to crumble. After application, however, a smooth, slippery film develops.
The preparation should be applied at bedtime to permit steroid contact with the lesion throughout the night. Depending on the severity of symptoms, it may be necessary to apply the preparation two or three times a day, preferably after meals. If significant repair or regeneration has not occurred in seven days, further investigation is advisable.
Oralone® (Triamcinolone Acetonide Dental Paste USP, 0.1%) is supplied in tubes containing 5 g of dental paste (NDC 51672–1335-5) and 7.5 g of dental paste (NDC 51672–1335-8).
Keep tightly closed. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Mfd. by: Taro Pharmaceuticals Inc.
Brampton, Ontario, Canada L6T 1C1
Dist. by: TaroPharma
a division of Taro Pharmaceuticals U.S.A., Inc.
Hawthorne, NY 10532
Oralone® and TaroPharma® are registered trademarks of Taro Pharmaceuticals U.S.A., Inc. and/or its affiliates.
Revised: July, 2010
PK-5417-1 104
0.1%
DENTAL
PASTE
Oralone®
Triamcinolone Acetonide
Dental Paste USP, 0.1%
FOR TOPICAL USE IN ADJUNCTIVE TREATMENT OF ORAL LESIONS
Keep this and all medications out of the reach of children.
NET WT 7.5 g
NDC 51672-1335-8
Rx only
TaroPharma®
| Oralone triamcinolone acetonide paste | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA070730 | 10/01/1986 | |
| Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE | |
Paxum may be available in the countries listed below.
Diazepam is reported as an ingredient of Paxum in the following countries:
International Drug Name Search
Mediflox may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Mediflox in the following countries:
Hydrocortisone is reported as an ingredient of Mediflox in the following countries:
International Drug Name Search
Gembit may be available in the countries listed below.
Gemfibrozil is reported as an ingredient of Gembit in the following countries:
International Drug Name Search
Gemcitabine Mylan Pharma may be available in the countries listed below.
Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemcitabine Mylan Pharma in the following countries:
International Drug Name Search
Bevitol may be available in the countries listed below.
Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Bevitol in the following countries:
International Drug Name Search
Halfdigoxin may be available in the countries listed below.
Digoxin is reported as an ingredient of Halfdigoxin in the following countries:
International Drug Name Search
Sucrase may be available in the countries listed below.
Sucralfate is reported as an ingredient of Sucrase in the following countries:
International Drug Name Search
Heptovir may be available in the countries listed below.
Lamivudine is reported as an ingredient of Heptovir in the following countries:
International Drug Name Search
Ecena may be available in the countries listed below.
Aceclofenac is reported as an ingredient of Ecena in the following countries:
International Drug Name Search
Ateblocor may be available in the countries listed below.
Atenolol is reported as an ingredient of Ateblocor in the following countries:
International Drug Name Search
Glimed may be available in the countries listed below.
Glimepiride is reported as an ingredient of Glimed in the following countries:
International Drug Name Search
Dompéridone Arrow may be available in the countries listed below.
Domperidone is reported as an ingredient of Dompéridone Arrow in the following countries:
International Drug Name Search
Tarodex may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Tarodex in the following countries:
International Drug Name Search
Migraspirina may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Migraspirina in the following countries:
International Drug Name Search
Digaol may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Digaol in the following countries:
International Drug Name Search
Oxaliplatino Ebewe may be available in the countries listed below.
Oxaliplatin is reported as an ingredient of Oxaliplatino Ebewe in the following countries:
International Drug Name Search
Pressyn may be available in the countries listed below.
Vasopressin is reported as an ingredient of Pressyn in the following countries:
International Drug Name Search
Lycinate may be available in the countries listed below.
Nitroglycerin is reported as an ingredient of Lycinate in the following countries:
International Drug Name Search
Ultratard HM may be available in the countries listed below.
Insulin Zinc Suspension (crystalline) human (a derivative of Insulin Zinc Suspension (crystalline)) is reported as an ingredient of Ultratard HM in the following countries:
International Drug Name Search
Zopiklon may be available in the countries listed below.
Zopiclone is reported as an ingredient of Zopiklon in the following countries:
International Drug Name Search
Amecid may be available in the countries listed below.
Quinfamide is reported as an ingredient of Amecid in the following countries:
International Drug Name Search
Heracillin may be available in the countries listed below.
Flucloxacillin magnesium salt (a derivative of Flucloxacillin) is reported as an ingredient of Heracillin in the following countries:
Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Heracillin in the following countries:
International Drug Name Search
Generic Name: zinc supplement (Oral route, Parenteral route)
In the U.S.
In Canada
Available Dosage Forms:
Zinc supplements are used to prevent or treat zinc deficiency.
The body needs zinc for normal growth and health. For patients who are unable to get enough zinc in their regular diet or who have a need for more zinc, zinc supplements may be necessary. They are generally taken by mouth but some patients may have to receive them by injection.
Zinc supplements may be used for other conditions as determined by your health care professional.
Lack of zinc may lead to poor night vision and wound-healing, a decrease in sense of taste and smell, a reduced ability to fight infections, and poor development of reproductive organs.
In addition, premature infants may need additional zinc.
Increased need for zinc should be determined by your health care professional.
Claims that zinc is effective in preventing vision loss in the elderly have not been proven. Zinc has not been proven effective in the treatment of porphyria.
Injectable zinc is given by or under the supervision of a health care professional. Other forms of zinc are available without a prescription.
Once a medicine or dietary supplement has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, zinc supplements are used in certain patients with the following medical condition:
For good health, it is important that you eat a balanced and varied diet. Follow carefully any diet program your health care professional may recommend. For your specific dietary vitamin and/or mineral needs, ask your health care professional for a list of appropriate foods. If you think that you are not getting enough vitamins and/or minerals in your diet, you may choose to take a dietary supplement.
Zinc is found in various foods, including lean red meats, seafood (especially herring and oysters), peas, and beans. Zinc is also found in whole grains; however, large amounts of whole-grains have been found to decrease the amount of zinc that is absorbed. Additional zinc may be added to the diet through treated (galvanized) cookware. Foods stored in uncoated tin cans may cause less zinc to be available for absorption from food.
The daily amount of zinc needed is defined in several different ways.
Normal daily recommended intakes in milligrams (mg) for zinc are generally defined as follows:
| Persons | U.S. (mg) | Canada (mg) |
| Infants and children birth to 3 years of age | 5–10 | 2–4 |
| Children 4 to 6 years of age | 10 | 5 |
| Children 7 to 10 years of age | 10 | 7–9 |
| Adolescent and adult males | 15 | 9–12 |
| Adolescent and adult females | 12 | 9 |
| Pregnant females | 15 | 15 |
| Breast-feeding females | 16–19 | 15 |
If you are taking a dietary supplement without a prescription, carefully read and follow any precautions on the label. For these supplements, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Problems in children have not been reported with intake of normal daily recommended amounts.
Problems in older adults have not been reported with intake of normal daily recommended amounts. There is some evidence that the elderly may be at risk of becoming deficient in zinc due to poor food selection, decreased absorption of zinc by the body, or medicines that decrease absorption of zinc or increase loss of zinc from the body.
It is especially important that you are receiving enough vitamins and minerals when you become pregnant and that you continue to receive the right amount of vitamins and minerals throughout your pregnancy. The healthy growth and development of the fetus depend on a steady supply of nutrients from the mother. There is evidence that low blood levels of zinc may lead to problems in pregnancy or defects in the baby. However, taking large amounts of a dietary supplement in pregnancy may be harmful to the mother and/or fetus and should be avoided.
It is important that you receive the right amounts of vitamins and minerals so that your baby will also get the vitamins and minerals needed to grow properly. However, taking large amounts of a dietary supplement while breast-feeding may be harmful to the mother and/or baby and should be avoided.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these dietary supplements, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using dietary supplements in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of dietary supplements in this class. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain zinc supplement. It may not be specific to Derma Gran. Please read with care.
Zinc supplements are most effective if they are taken at least 1 hour before or 2 hours after meals. However, if zinc supplements cause stomach upset, they may be taken with a meal. You should tell your health care professional if you are taking your zinc supplement with meals.
The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
If you miss taking zinc supplements for one or more days there is no cause for concern, since it takes some time for your body to become seriously low in zinc. However, if your health care professional has recommended that you take zinc, try to remember to take it as directed every day.
Keep out of the reach of children.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Do not keep outdated medicine or medicine no longer needed.
When zinc combines with certain foods it may not be absorbed into your body and it will do you no good. If you are taking zinc, the following foods should be avoided or taken 2 hours after you take zinc:
Do not take zinc supplements and copper, iron, or phosphorus supplements at the same time. It is best to space doses of these products 2 hours apart, to get the full benefit from each dietary supplement.
Along with its needed effects, a dietary supplement may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
